Stay updated on ABBV-105/Upadacitinib Combo Follow-Up Clinical Trial

Sign up to get notified when there's something new on the ABBV-105/Upadacitinib Combo Follow-Up Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ABBV-105/Upadacitinib Combo Follow-Up Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision updated from v3.3.1 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-12-01T18:34:39.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    Revision updated from v3.2.0 to v3.3.1; a minor metadata banner change that does not affect content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-24T14:56:48.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The page no longer displays a notice about government-funding/operational status. This previously advised that information may be out of date and linked to status updates.
    Difference
    0.3%
    Check dated 2025-11-17T07:17:05.000Z thumbnail image
  4. Check
    34 days ago
    Change Detected
    Summary
    The new page shows minor formatting tweaks and small text edits without altering core study information such as eligibility criteria, interventions, outcomes, or listed locations.
    Difference
    0.3%
    Check dated 2025-11-03T01:29:43.000Z thumbnail image
  5. Check
    63 days ago
    Change Detected
    Summary
    - Added a prominent notice about potential outages due to lapse in government funding and updated operating status guidance. - Updated version from v3.1.0 to v3.2.0.
    Difference
    2%
    Check dated 2025-10-05T10:30:31.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.1.0 and removes several drug-safety related sections (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs), indicating a content pruning aligned with a versioned update.
    Difference
    0.2%
    Check dated 2025-09-28T03:20:53.000Z thumbnail image

Stay in the know with updates to ABBV-105/Upadacitinib Combo Follow-Up Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ABBV-105/Upadacitinib Combo Follow-Up Clinical Trial page.